Omega-3 Fatty Acid Ethyl Esters (Lotriga) Granular Capsules Special Drug Use Surveillance (Long-term Use Survey)
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2019
Price : $35 *
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hyperlipidaemia
- Focus Adverse reactions
- Sponsors Takeda
- 20 Oct 2016 Status changed from active, no longer recruiting to completed.
- 02 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Jun 2014 New trial record